Albemarle Corporation Stock

Equities

ALB

US0126531013

Specialty Chemicals

Market Closed - Nyse 04:00:01 2024-05-28 pm EDT Pre-market 07:52:18 am
127.8 USD +0.13% Intraday chart for Albemarle Corporation 127.6 -0.12%
Sales 2024 * 5.89B Sales 2025 * 7.24B Capitalization 15.02B
Net income 2024 * 360M Net income 2025 * 1.56B EV / Sales 2024 * 3.31 x
Net Debt 2024 * 4.5B Net Debt 2025 * 4.19B EV / Sales 2025 * 2.65 x
P/E ratio 2024 *
44 x
P/E ratio 2025 *
9.6 x
Employees 9,000
Yield 2024 *
1.24%
Yield 2025 *
1.27%
Free-Float 99.68%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.13%
1 week+0.88%
Current month+6.19%
1 month+9.31%
3 months-3.26%
6 months+3.11%
Current year-11.57%
More quotes
1 week
122.67
Extreme 122.67
129.50
1 month
117.35
Extreme 117.35
137.50
Current year
106.69
Extreme 106.69
149.61
1 year
106.69
Extreme 106.69
247.44
3 years
106.69
Extreme 106.69
334.55
5 years
48.89
Extreme 48.8901
334.55
10 years
41.37
Extreme 41.37
334.55
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 15-01-11
Director of Finance/CFO 47 Nov. 05
Chief Tech/Sci/R&D Officer - 18-04-16
Members of the board TitleAgeSince
Director/Board Member 69 12-07-11
Director/Board Member 63 13-06-30
Director/Board Member 67 19-07-22
More insiders
Date Price Change Volume
24-05-28 127.8 +0.13% 2,105,265
24-05-24 127.6 +3.77% 1,445,741
24-05-23 123 -2.79% 1,754,358
24-05-22 126.5 -0.13% 2,423,548
24-05-21 126.6 -2.70% 1,655,269

Delayed Quote Nyse, May 28, 2024 at 04:00 pm EDT

More quotes
Albemarle Corporation is one of the world's leading manufacturers of specialty chemicals. The group's products are aimed primarily at the petroleum refining, energy storage, consumer electronics, construction, crop protection, automotive, food safety and pharmaceuticals industries. Net sales break down by family of products as follows: - lithium and polymer solutions (73.6%); - bromine (15.4%); - catalysts (11%). Exports account for 90.3% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
127.8 USD
Average target price
153.8 USD
Spread / Average Target
+20.36%
Consensus